An official website of the United States government
These tables are also available in a printable version (PDF, 236 KB).
2013 Comprehensive ICD-9-CM Casefinding Code List for Reportable Tumors
| ICD-9-CM code* | Explanation of ICD-9-CM code |
|---|---|
| 140._ - 172._, 174._ - 209.36, 209.7 | Malignant neoplasms stated or presumed to be primary (of specified sites), and certain specified histologies |
| 173.00, 173.09, 173.10, 173.19 | Unspecified and other specified malignant neoplasm of skin of lip and eyelid, including canthus |
| 173.20, 173.29, 173.30, 173.39 | Unspecified and other specified malignant neoplasm of ear and skin of other and unspecified parts of face |
| 173.40, 173.49, 173.50, 173.59 | Unspecified and other specified malignant neoplasm of scalp and skin of neck and skin of trunk, except scrotum |
| 173.60, 173.69, 173.70, 173.79 | Unspecified and other specified malignant neoplasm of skin of upper limb, including shoulder and lower limb, including hip |
| 173.80, 173.89, 173.90, 173.99 | Unspecified and other specified malignant neoplasm of other specified sites of skin and site unspecified |
| 225.0 - 225.9 | Benign neoplasm of brain and spinal cord neoplasm |
| 227.3, 227.4 | Benign neoplasm of pituitary gland, craniopharyngeal duct (pouch) and pineal gland |
| 228.02 | Hemangioma; of intracranial structures |
| 228.1 | Lymphangioma, any site |
| 230.0 - 234.9 | Carcinoma in situ |
| 237.0 - 237.1 | Neoplasm of uncertain behavior of endocrine glands and nervous system: pituitary gland, craniopharyngeal duct and pineal gland |
| 237.5, 237.6, 237.9 | Neoplasm of uncertain behavior [borderline] of brain, spinal cord and meninges and unspecified parts of nervous system |
| 238.4 | Polycythemia vera (9950) |
| 238.6 | Plasma cells |
| 238.7_ | Other lymphatic and hematopoietic tissues |
| 239.6, 239.7 | Neoplasms of unspecified nature, brain, other parts nervous system |
| 273.3 | Macroglobulinemia |
| 277.89 | Other specified disorders of metabolism |
| 288.4 | Hemophagocytic syndrome (9751, 9754) |
The following codes are not reportable per se, but they should alert registrars to look for the first malignant neoplasm associated with these codes.
2013 Supplementary List #1 ICD-9-CM Codes That Should Be Followed by or Associated with a Neoplasm Code
| ICD-9-CM code* | Explanation of ICD-9-CM code |
|---|---|
| 258.0_ | Polyglandular activity in multiple endocrine adenomatosis [MEN] |
| 284.2 | Myelophthisis |
| 285.22 | Anemia in neoplastic disease |
| 289.83 | Myelofibrosis (9961/3) |
| 331.7 | Cerebral degeneration in diseases classified elsewhere |
| 336.3 | Myelopathy in other diseases classified elsewhere |
| 357.3 | Polyneuropathy in malignant disease |
| 358.1 | Myasthenic syndromes in other diseases classified elsewhere |
| 358.31 | Eaton-Lambert syndrome in neoplastic disease |
| 511.81 | Malignant pleural effusion |
| 512.82 | Secondary spontaneous pneumothorax |
| 731.1_ | Osteitis deformans in diseases classified elsewhere |
| 731.3 | Major osseous defect |
| 789.51 | Malignant ascites |
| V07.5_ | Prophylactic use of agents affecting estrogen receptors and estrogen levels |
| V58.42 | Aftercare following surgery for neoplasm |
NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.
2013 Supplementary List #2 ICD-9-CM Code List to Screen for Cancer Registry Cases Not Identified by Other Codes
| ICD-9-CM code* | Explanation of ICD-9-CM code |
|---|---|
| 042 | Acquired Immunodeficiency Syndrome (AIDS) |
| 079.4, 079.5_ | Human papillomavirus; Retrovirus (HTLV, types I, II and 2) |
| 173.01, 173.02, 173.11, 173.12 | Basal and squamous cell carcinoma of skin of lip and eyelid, including canthus |
| 173.21, 173.22, 173.31, 173.32 | Basal and squamous cell carcinoma of ear and skin of other and unspecified parts |
| 173.41, 173.42, 173.51, 173.52 | Basal and squamous cell carcinoma of scalp and skin of neck and skin of trunk, except scrotum |
| 173.61, 173.62, 173.71, 173.72 | Basal and squamous cell carcinoma of skin of upper limb, including shoulder and lower limb, including hip |
| 173.81, 173.82, 173.91, 173.92 | Basal and squamous cell carcinoma of other specified sites of skin and site unspecified |
| 209.40 - 209.69 | Benign carcinoid tumors |
| 210.0 - 229.9 | Benign neoplasms (except for 225.0-225.9, 227.3, 227.4, 228.02, and 228.1, which are listed in the Reportable list) |
| 235.0 - 239.9 | Neoplasms of uncertain behavior (except for 237.0, 237.1, 237.5, 237.6, 237.9, 238.4, 238.6, 238.7_, 239.6, 239.7) , |
| 249.20 | Secondary diabetes with hypersmolarity |
| 273.0, 273.1, 273.2, 273.8, 273.9 | Disorders of plasma protein metabolism |
| 277.88 | Tumor lysis syndrome (following neoplastic chemotherapy) |
| 279.02, 279.03, 279.05, 279.12 | Select IgM immunodeficiency and other immunoglobulin deficiencies Note: Associated with lymphoproliferative disorders |
| 279.2, 279.3 | Combined and unspecified immunity deficiency |
| 279.41, 279.49 | Autoimmune lymphoproliferative syndrome |
| 279.50 - 279.53 | Graft-versus host disease |
| 279.8, 279.9 | Other and unspecified disorders involving the immune mechanism |
| 284.1_ | Pancytopenia |
| 284.81 - 284.9 | Other and unspecified aplastic anemias |
| 285.0 | Sideroblastic anemia |
| 285.3 | Anemia due to antineoplastic chemotherapy |
| 287.39, 287.49, 287.5 | Other primary, secondary and unspecified thrombocytopenia |
| 288.03 | Drug induced neutropenia |
| 288.3 | Eosinophilia |
| 289.89, 289.9 | Other specified diseases of blood and blood forming organs |
| 323.81 | Other causes of encephalitis and encephalomyelitis |
| 337.9 | Unspecified disorders of autonomic nervous system |
| 338.3 | Neoplasm related pain (acute)(chronic) |
| 352.9 | Unspecified disorder of cranial nerves |
| 353.8 | Other nerve root and plexus disorders |
| 516.5 | Adult pulmonary Langerhans cell histiocytosis |
| 569.44 | Dysplasia of anus (Anal intraepithelial neoplasia [AIN I and II]) |
| 602.3 | Dysplasia of prostate (Prostatic intraepithelial neoplasia [PIN I and II]) |
| 622.1_ | Dysplasia of cervix (CIN I, II and unspecified) |
| 623.0 | Dysplasia of vagina (Vaginal intraepithelial neoplasia [VAIN I and II] |
| 624.0_ | Dystrophy of vulva (Vulvar intraepithelial neoplasia [VIN I and II] |
| 630 | Hydatidiform mole |
| 648.9_ | Other current conditions classifiable elsewhere |
| 713.8 | Arthropathy associated with other conditions classified elsewhere |
| 728.9 | Unspecified disorder of muscle, ligament, and fascia |
| 733.1_ | Pathologic fracture |
| 758.0 | Down's Syndrome |
| 780.79 | Neoplastic (malignant) related fatigue |
| 785.6 | Enlargement of lymph nodes |
| 789.51 | Malignant ascites |
| 790.93 | Elevated prostate specific antigen (PSA) |
| 791.9 | Other non specific findings on examination of urine |
| 792.0, 792.2, 792.4, 792.9 | Non specified abnormal findings in specified and unspecified body structures |
| 793.11 | Solitary pulmonary nodule |
| 793.8_ | Nonspecific (abnormal) findings on radiological and examination of body structure (breast) |
| 795.0_, 795.1_, 795.4, 796.7_ | Papanicolaou smear of cervix, vagina, anus and other with cytologic evidence of malignancy |
| 795.8_ | Abnormal tumor markers |
| 962.1, 963.1 | Poisoning by hormones ,antineoplastic, immunosuppressive drugs |
| 990 | Effects of radiation, unspecified |
| 996.54 | Mechanical complication of other specified prosthetic device, implant, and graft-due to breast prosthesis |
| 996.85 | Complication of transplanted organ |
| 999.3_ | Other infection due to central venous catheter, transfusion, infusion |
| E858.0 - E858.2 | Accidental poisonings |
| E873.2 | Failure in dosage, overdose of radiation in therapy |
| E878.0 | Abnormal reaction of surgical operation with transplant of whole organ |
| E879.2 | Overdose of radiation given during therapy |
| E930.7 | Adverse reaction of antineoplastic therapy-Antineoplastic antibiotics |
| E932.1 | Adverse reaction to antineoplastic therapy |
| E933.1 | Adverse effect of immunosuppressive drugs |
| V10.0_ - V10.9_ | Personal history of malignancy |
| V12.41 | Personal history of benign neoplasm of the brain |
| V13.89 | Personal history of unspecified malignant neoplasm and history of in-situ neoplasm of other site |
| V15.22 | Personal history of undergoing in utero procedure during pregnancy |
| V15.3 | Other personal history presenting hazards to health or radiation |
| V16._ | Family history of malignant neoplasm |
| V42.81, V42.82 | Organ or tissue replaced by transplants |
| V51.0 | Encounter for breast reconstruction following mastectomy |
| V52.4 | Fitting and adjustment of prosthetic device and implant (breast) |
| V54.2_ | Aftercare for healing pathologic fracture |
| V58.0, V58.1_ | Encounter for radiation, chemotherapy and immunotherapy |
| V66.1, V66.2, V66.7 | Convalescence and palliative care |
| V67.1, V67.2 | Follow up examinations |
| V71.1 | Observation for suspected malignant diseases |
| V72.83 | Other specified pre-operative examination |
| V76._ | Special screening for malignant neoplasms |
| V78.8, V78.9 | Other and unspecified disorders of blood and blood forming organs |
| V86._ | Estrogen receptor status |
| V87.41, V87.43, V87.46 | Personal history of drug therapy: antineoplastic chemotherapy, estrogen therapy and immunosuppression therapy |
The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the supplemental list and are now in their own list.
| ICD-9-CM Code* | Explanation of ICD-9-CM Code |
|---|---|
| 253.6 | Syndrome of inappropriate secretion of antidiuretic hormone |
| 259.2 | Carcinoid syndrome |
| 259.8 | Other specified endocrine disorders |
| 275.42 | Hypercalcemia |
| 379.5_ | Nystagmus and other irregular eye movements |
| 686.01 | Pyoderma gangrenosum |
| 694.4 | Pemphigus |
| 695.89 | Other specified erythematous conditions |
| 701.2 | Acquired acanthosis nigricans |
| 710.3 | Dermatomyositis |
| 710.4 | Polymyositis |
*International Classification of Diseases, 9th Revision, Clinical Modification, Sixth Edition (Hospital Edition), 2012
